This federal contract award is for the delivery of Valsartan-HCTZ 160-25 mg tablets, with a ceiling value of $9,597.58. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award does not have a set-aside designation, indicating open competition. The contract is for a firm fixed price and has an ultimate completion date of December 3, 2024.
Generated 3/3/25, 12:32 PM